Form
SCHEDULE 13G/A
Passive or exempt beneficial ownership filing.
Medicxi Growth I LP - 30 Jun 2026 SCHEDULE 13G/A Report for Centessa Pharmaceuticals plc Ordinary Shares, nominal value 0.002 per share (CNTA)
- Filing manager
- Medicxi Growth I LP
- Reporting owner
- Medicxi Growth I LP
- Beneficially owned shares
- 0 shares
- Large-stake signal
-
Ownership
0%Beneficial ownership of this reported class.
Shares
0 sharesShares beneficially owned as disclosed.
Event date
30 Jun 2026Date tied to the ownership event or amendment.
Accepted by SEC
04 Aug 2026EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 0%
- Symbol
- CNTA
- SEC form
- SCHEDULE 13G/A
- Accepted by SEC
- 04 Aug 2026, 11:41:35 UTC
- Event date
- 30 Jun 2026
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
1 source field
Source evidence
Original filing metadata and source links for verification.
4 source fields
Key filing fact
Medicxi Growth I LP disclosed 0% ownership in Centessa Pharmaceuticals plc Ordinary Shares, nominal value 0.002 per share (CNTA) on 30 Jun 2026.
Key facts
- Medicxi Growth I LP filed SCHEDULE 13G/A for Centessa Pharmaceuticals plc Ordinary Shares, nominal value 0.002 per share (CNTA).
- Disclosed ownership: 0%.
- Date of event: 30 Jun 2026.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 04 Aug 2026, 11:41.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (10)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Medicxi Growth I LP | 0% | 0 | 0 | 0 | /s/ Francois Chesnay | Francois Chesnay, Director of Manager | |
| Medicxi Growth Co-Invest I LP | 0% | 0 | 0 | 0 | /s/ Francois Chesnay | Francois Chesnay, Director of Manager | |
| Medicxi Growth I GP Limited | 0% | 0 | 0 | 0 | /s/ Francois Chesnay | Francois Chesnay, Director | |
| Medicxi Ventures I LP | 0% | 0 | 0 | 0 | /s/ Francois Chesnay | Francois Chesnay, Director of Manager | |
| Medicxi Co-Invest I LP | 0% | 0 | 0 | 0 | /s/ Francois Chesnay | Francois Chesnay, Director of Manager | |
| Medicxi Ventures I GP Limited | 0% | 0 | 0 | 0 | /s/ Francois Chesnay | Francois Chesnay, Director | |
| Medicxi Secondary I LP | 0% | 0 | 0 | 0 | /s/ Francois Chesnay | Francois Chesnay, Director of Manager | |
| Medicxi Secondary Co-Invest I LP | 0% | 0 | 0 | 0 | /s/ Francois Chesnay | Francois Chesnay, Director of Manager | |
| Medicxi Secondary I GP Limited | 0% | 0 | 0 | 0 | /s/ Francois Chesnay | Francois Chesnay, Director | |
| Medicxi Ventures Management (Jersey) Limited | 0% | 0 | 0 | 0 | /s/ Francois Chesnay | Francois Chesnay, Director |
CIK / CUSIP context first